Biotech Values

[acgood]

Your skepticism about teva complicating its ANDA is a good point. I guess we will have to wait and see for the moment. Here are the benefits touted by Antares for Vibex-

Benefits of Vibex™ Disposable Mini-Needle Injectors
Rapid injection
Eliminates sharps disposal
Ease of use in emergencies
Reduces psychological barriers since the patient never sees the needle
Highly dependable subcutaneous injection
Designed around conventional cartridges or pre-filled syringes

If I heard correctly on teh AIS call, the company said ANDAs had been filed for both Teva Vibex products, so that would seem to rule out copaxone...seems too early to launch a differentiated copaxone branded generic to compete with possible future generic from mnta/sandoz